Original language | English (US) |
---|---|
Pages (from-to) | 1197-1202 |
Number of pages | 6 |
Journal | Leukemia |
Volume | 35 |
Issue number | 4 |
DOIs | |
State | Published - Apr 2021 |
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide. / for the RESUME trialists.
In: Leukemia, Vol. 35, No. 4, 04.2021, p. 1197-1202.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide
AU - for the RESUME trialists
AU - Chowdhury, Onima
AU - O’Sullivan, Jennifer
AU - Barkas, Nikolaos
AU - Wang, Guanlin
AU - Buck, Gemma
AU - Hamblin, Angela
AU - Tefferi, Ayalew
AU - Al-Ali, Haifa K.
AU - Barosi, Giovanni
AU - Devos, Timothy
AU - Gisslinger, Heinz
AU - Jiang, Qian
AU - Kiladjian, Jean Jacques
AU - Mesa, Ruben
AU - Passamonti, Francesco
AU - Ribrag, Vincent
AU - Schiller, Gary
AU - Vannucchi, Alessandro M.
AU - Zhou, Daobin
AU - McMullin, Mary Frances
AU - Zhong, Jianhua
AU - Gale, Robert Peter
AU - Mead, Adam J.
AU - Catalano, John
AU - Stevenson, William
AU - Gastl, Günther
AU - Linkesch, Werner
AU - Van Droogenbroeck, Jan
AU - Mineur, Philippe
AU - Gupta, Vikas
AU - Turner, Andrew
AU - Nevill, Thomas
AU - Li, Jianyong
AU - Shen, Zhixiang
AU - Liu, Ting
AU - Bordessoule, Dominique
AU - Natarajan-Amé, Shanti
AU - Recher, Christian
AU - Demory, Jean Loup
AU - Schlenk, Richard
AU - Griesshammer, Martin
AU - Cazzola, Mario
AU - Saglio, Giuseppe
AU - Specchia, Giorgina
AU - Rambaldi, Alessandro
AU - Pane, Fabrizio
AU - Zweegman, Sonja
AU - te Boekhorst, Peter
AU - Raymakers, Reinier
AU - Abdulkadyrov, Kudrat
N1 - Funding Information: Acknowledgements Supported in part by a National Institute for Health Research (NIHR) academic clinical lectureship (OC), the John Fell Fund, a Medical Research Council Senior Clinical Fellowship (AJM, MR/l006340/1), a Cancer Research UK (CRUK) Senior Cancer Research Fellowship. RPG acknowledges support from the National Institute of Health Research (NIHR) Biomedical Research Centre funding scheme. Supported in part by an unrestricted educational grant from Celgene Corp.
PY - 2021/4
Y1 - 2021/4
UR - http://www.scopus.com/inward/record.url?scp=85089142992&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089142992&partnerID=8YFLogxK
U2 - 10.1038/s41375-020-0979-6
DO - 10.1038/s41375-020-0979-6
M3 - Article
C2 - 32770086
AN - SCOPUS:85089142992
SN - 0887-6924
VL - 35
SP - 1197
EP - 1202
JO - Leukemia
JF - Leukemia
IS - 4
ER -